Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the world's leading drugmakers, missed last ...
Scientists have developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people ...
The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...
There appears to be limited evidence supporting the use of epidural steroid injections for certain types of chronic lower ...
Researchers found that epidural steroid injections may modestly reduce pain and disability in patients with a pinched nerve ...
Experts have finally ended the debate about steroid shots for the back pain in the new study.According to HealthDay, ...
Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic ...
WINTER bugs are rife, and norovirus is proving really nasty at the moment. Hospital admissions are at a high, hitting more ...
Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...